Across TCGA pan-cancer cohorts, MIR105-2 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MIR105-2 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR105-2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR105-2 expression acts as an unfavorable survival marker.

BLCA and STAD are the cancer types where MIR105-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.152	0.625	.012	54	view →
STAD	DFS	Tertile	All	0.264	0.722	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR105-2 tumor-vs-normal RNA expression · all MIR105-2 data types